Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

PURPOSE: Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PF...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: McCarthy, Philip L., Holstein, Sarah A., Petrucci, Maria Teresa, Richardson, Paul G., Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D., Palumbo, Antonio, Attal, Michel
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2017
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652871/
https://ncbi.nlm.nih.gov/pubmed/28742454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.6679
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars